| Literature DB >> 32823648 |
Nataša K Rančić1, Milan B Golubović2, Mirko V Ilić3, Aleksanda S Ignjatović1, Radomir M Živadinović1, Saša N Đenić4, Stefan D Momčilović5, Biljana N Kocić1, Zoran G Milošević1, Suzana A Otašević1.
Abstract
Background and objectives: Persistent infection with carcinogenic human papillomavirus (HPV) is the leading cause of cervical cancer. The study explored students' knowledge about cervical cancer and awareness of human papillomavirus and the HPV vaccine. Materials andEntities:
Keywords: HPV; HPV vaccine; awareness; cervical cancer; knowledge; student population
Mesh:
Substances:
Year: 2020 PMID: 32823648 PMCID: PMC7466248 DOI: 10.3390/medicina56080406
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Socio-demographic characteristics of the participants.
| Variable | N | (%) |
|---|---|---|
|
| ||
| Medical | 229 | (14.2) |
| Other | 1387 | (85.2) |
|
| ||
| Grammar school | 665 | (41.1) |
| Other, non-medical high school | 709 | (43.9) |
| Medical high school | 242 | (15) |
|
| ||
| Urban area | 1224 | (75.7) |
| Rural area | 392 | (24.3) |
|
| ||
| Low | 81 | (5) |
| Middle | 1000 | (62) |
| High | 531 | (33) |
|
| ||
| Low | 47 | (2.9) |
| Middle | 940 | (59.1) |
| High | 604 | (38) |
|
| ||
| Low | 159 | (9.8) |
| Middle | 825 | (51.1) |
| High | 632 | (39.1) |
|
| ||
| Single | 890 | (55.1) |
| In relationship | 726 | (44.9) |
|
| ||
| Yes | 820 | (50.7) |
| No | 796 | (49.3) |
|
| ||
| 1 | 526 | (64.1) |
| 2–4 | 272 | (33.2) |
| 5+ | 22 | (2.7) |
a Missing data due to death of a parent; b Other response options were not chosen by our participants; c Of those that had had sexual intercourse; 5+—five and more.
Association of participants’ socio-demographic characteristics with cervical cancer knowledge score.
| Variable | Cervical Cancer |
|
|---|---|---|
| Knowledge Score | ||
|
| <0.001 | |
| Medical | 21.21 ± 5.73 | |
| Other | 15.54 ± 7.94 | |
|
| <0.001 | |
| Grammar school | 16.79 ± 7.73 | |
| Other, non-medical high school | 14.69 ± 7.98 a,b | |
| Medical high school | 20.82 ± 6.38 b | |
|
| 0.01 | |
| Urban area | 16.62 ± 7.82 | |
| Rural area | 15.48 ± 8.16 | |
|
| <0.001 | |
| Low | 13.33 ± 8.27 c,d | |
| Middle | 16.22 ± 8.04 | |
| High | 17.02 ± 7.53 | |
|
| 0.006 | |
| Low | 15.68 ± 7.82 | |
| Middle | 15.78 ± 8.09 | |
| High | 17.22 ± 7.57 e | |
|
| 0.008 | |
| Low | 14.25 ± 8.53 | |
| Middle | 16.62 ± 7.85 f | |
| High | 16.51 ± 7.79 f | |
|
| 0.019 | |
| Single | 15.89 ± 8.06 | |
| In relationship | 16.96 ± 7.69 | |
|
| 0.065 | |
| Yes | 16.67 ± 7.90 | |
| No | 16.01 ± 7.93 | |
|
| 0.537 | |
| 1 | 16.65 ± 7.80 | |
| 2–4 | 16.96 ± 8.08 | |
| 5+ | 17.00 ± 8.45 |
a Vs. medical high school, p < 0.05; b vs. grammar school, p < 0.05; c vs. middle educated mother, p < 0.05; d vs. high educated mother, p < 0.05; e vs. middle educated father, p < 0.05, f vs. low income, p < 0.05; g of those that had had sexual intercourse; 5+—five and more.
Association of participants’ socio-demographic characteristics with HPV and HPV vaccine awareness.
| Heard about HPV | Heard about HPV Vaccine a
| Know When the Best Time to Get the HPV Vaccine is b
| Know that HPV Vaccine is Available in Serbia b
| |||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Medical | 155 | 67.7 | 50 | 32.3 | 10 | 6.5 | 15 | 9.7 |
| Other | 633 | 45.6 | 179 | 28.3 | 27 | 4.3 | 33 | 5.2 |
| <0.001 | 0.379 | 0.249 | 0.037 | |||||
|
| ||||||||
| Grammar school | 295 ** | 44.4 | 84 | 28.5 | 14 | 4.7 | 16 | 5.4 |
| Other, non-medical high schools | 303 ** | 42.7 | 79 | 26.1 | 15 | 5.0 | 19 | 6.3 |
| Medical high school | 190 | 78.5 | 66 | 34.7 | 8 | 4.2 | 13 | 6.8 |
| <0.001 | 0.119 | 0.930 | 0.805 | |||||
|
| ||||||||
| Urban area | 603 | 49.3 | 172 | 28.5 | 29 | 4.8 | 38 | 6.3 |
| Rural area | 185 | 47.2 | 57 | 30.8 | 8 | 4.3 | 10 | 5.4 |
| 0.512 | 0.612 | 0.785 | 0.656 | |||||
|
| ||||||||
| Low | 43 | 53.1 | 6 *** | 14.0 | 1 | 2.3 | 0 | 0.0 |
| Middle | 475 | 47.5 | 138 | 28.8 | 20 | 4.2 | 26 | 5.5 |
| High | 268 | 50.5 | 85 | 31.7 | 16 | 6.0 | 22 | 8.2 |
| 0.394 | 0.041 | 0.415 | 0.074 | |||||
|
| ||||||||
| Low | 20 | 42.6 | 8 | 40.0 | 1 | 5.0 | 1 | 5.0 |
| Middle | 466 | 49.6 | 133 | 28.5 | 18 | 3.9 | 26 | 5.6 |
| High | 295 | 48.8 | 86 | 29.2 | 18 | 6.1 | 20 | 6.8 |
| 0.634 | 0.561 | 0.366 | 0.780 | |||||
|
| ||||||||
| Low | 73 | 45.9 | 22 | 30.1 | 4 | 5.5 | 3 | 4.1 |
| Middle | 388 | 47 | 110 | 28.4 | 18 | 4.6 | 31 | 8.0 |
| High | 327 | 57.1 | 97 | 29.7 | 15 | 4.6 | 14 | 4.3 |
| 0.153 | 0.908 | 0.946 | 0.090 | |||||
|
| ||||||||
| Single | 406 | 45.6 | 105 | 25.9 | 14 | 3.4 | 20 | 4.9 |
| In relationship | 382 | 52.6 | 124 | 32.5 | 23 | 6.0 | 28 | 7.3 |
| 0.005 | 0.041 | 0.088 | 0.159 | |||||
|
| ||||||||
| Yes | 435 | 53.0 | 148 | 34.0 | 21 | 4.8 | 31 | 7.1 |
| No | 353 | 44.3 | 81 | 22.9 | 16 | 4.5 | 17 | 4.8 |
| 0.001 | 0.001 | 0.846 | 0.177 | |||||
|
| ||||||||
| 1 | 274 | 52.1 | 97 | 35.4 | 15 | 5.5 | 19 | 6.9 |
| 2–4 | 149 | 54.8 | 45 | 30.2 | 4 | 2.7 | 11 | 7.4 |
| 5+ | 12 | 54.5 | 6 | 50.0 | 2 | 16.7 | 1 | 8.3 |
| 0.763 | 0.285 | 0.067 | 0.972 | |||||
* Chi-squared test; ** vs. medical high school, p < 0.05; *** vs. high educated mother, p < 0.05; a only those that had also heard about HPV were taken into account; b only those that had heard about HPV and the HPV vaccine were taken into account; c missing data due to death of a parent; d of those that had had sexual intercourse; 1—not significant; 5+—five and more; Human papillomavirus—HPV.
Source of information and its association with cervical cancer knowledge score, HPV and HPV vaccine awareness.
| Source of Information | Knowledge Score about Cervical Cancer | Heard about HPV | Heard about HPV Vaccine a | Know the Best Time to Get the HPV Vaccine b | Know that HPV Vaccine is Available in Serbia b | ||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||
| Yes | 17.38 ± 7.52 | 532 | 67.5 | 158 | 69.0 | 29 | 78.4 | 34 | 70.8 |
| No | 14.62 ± 8.28 | 256 | 32.5 | 71 | 31.0 | 8 | 21.6 | 14 | 29.2 |
|
| <0.001 * | <0.001 *** | 0.628 *** | 0.249 *** | 0.893 *** | ||||
|
| |||||||||
| Yes | 18.49 ± 7.15 | 512 | 65.0 | 170 | 74.2 | 33 | 89.2 | 42 | 87.5 |
| No | 13.87 ± 8.05 | 276 | 35.0 | 59 | 25.8 | 4 | 10.8 | 6 | 12.5 |
|
| <0.001 * | <0.001 *** | <0.001 *** | 0.039 *** | 0.029 *** | ||||
|
| |||||||||
| Yes | 18.42 ± 6.98 | 298 | 37.8 | 94 | 41.0 | 17 | 45.9 | 20 | 41.7 |
| No | 15.31 ± 8.16 | 490 | 62.2 | 135 | 59.0 | 20 | 54.1 | 28 | 58.3 |
|
| <0.001 ** | <0.001 *** | 0.264 *** | 0.632 *** | 0.922 *** | ||||
* Mann–Whitney test; ** independent t-test; *** chi-squared test; a Only those who had also heard about HPV were taken into account; b Only those who had heard about HPV and the HPV vaccine were taken into account; c OHE—organized health education.